Categories Energy

SemGroup’s stock jumps on deal with Energy Transfer

SemGroup Corporation’s (NYSE: SEMG) shares were up 62% in midday trade on Monday after the company announced that it will be acquired by Energy Transfer LP (NYSE: ET) for around $5.1 billion, including debt. Shares of Energy Transfer were down 3.6%.  

Chesapeake Energy Q2 earnings review
(Image for representation only/Photo Courtesy: Zbynek Burival on Unsplash)

Under the terms, SemGroup shareholders will receive $6.80 per share in cash and 0.7275 of an ET common unit for each SemGroup share, or approx. 40% cash and 60% equity. The deal represents a 65% premium to SemGroup’s closing share price on Friday. Upon close of the transaction, SemGroup shareholders are expected to own approx. 2.2% of ET’s outstanding common units.

The deal is expected to close by late 2019 or early 2020, subject to approvals. This acquisition will expand Energy Transfer’s geographic footprint and help increase the connectivity for its crude oil and NGL transportation businesses.

Also read: US energy stocks gain from oil field destruction at Aramco

The transaction will also help in expanding Energy Transfer’s crude oil and NGL infrastructure through the addition of assets and pipelines in Colorado and Oklahoma. The deal is expected to be immediately accretive to distributable cash flow per common unit.

The combined entity expects to generate more than $170 million of annual run-rate synergies, comprising commercial and operational synergies of $80 million, financial savings of $50 million and cost savings of $40 million.

In its most recent quarter, SemGroup reported revenues of $675 million and net loss attributable to common shareholders of $35 million, or $0.45 per share.

Follow our Google News edition to get the latest stock market, earnings and financial news at your fingertips.

Most Popular

Intensity Therapeutics is establishing a new field of localized cancer reduction: CEO

Intensity Therapeutics, Inc. (NASDAQ: INTS) is a clinical biotechnology company engaged in the discovery development, and commercialization of first-in-class cancer drugs that attenuate tumors with minimal side effects while training

INTU Earnings: Intuit Q1 2025 adj. profit rises on higher revenues

Financial technology company Intuit Inc. (NASDAQ: INTU) Thursday announced results for the first quarter of 2025, reporting a modest increase in adjusted earnings. The Mountain View-headquartered company’s first-quarter revenue came

Riding the AI wave, Nvidia looks set to stay on the high-growth path

After delivering strong results for the third quarter, Nvidia Corporation (NASDAQ: NVDA) this week said the launch of its new-generation Blackwell chip is on track. The company is thriving on

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top